-
Je něco špatně v tomto záznamu ?
Development of LC-HRMS methods for evaluation of metabolic conversion of 5-fluorocytosine at GDEPT procedure
P. Skvara, E. Durinikova, K. Grabicová, E. Mordacikova, M. Matuskova, A. Vojs Stanova
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- chromatografie kapalinová MeSH
- cytosindeaminasa MeSH
- flucytosin * MeSH
- fluorouracil MeSH
- hmotnostní spektrometrie MeSH
- prekurzory léčiv * MeSH
- Publikační typ
- časopisecké články MeSH
Gene-directed enzyme/prodrug therapy represents one of the experimental treatment approaches. The system based on conversion of nontoxic prodrug 5-fluorocytosine to chemotherapeutic 5-fluorouracil by cytosine deaminase or fusion cytosine deaminase::uracil phosphoribosyl transferase belongs to the most frequently used. The detailed analysis of 5-fluorocytosine, 5-fluorouracil and its metabolites enables to understand various responses of tumour cells to treatment as well as mechanisms of resistance. A fast, sensitive and accurate methods based on liquid chromatography with high-resolution mass spectrometry (LC-HRMS) for the identification and quantification of 5-fluorocytosine, 5-fluorouracil and its major metabolites were developed. Two different hybrid high-resolution mass spectrometers sufficient for study of metabolic pathways were used. The LC-ESI IT-TOF MS method was successfully used for identification of 5-fluorocytosine, 5-fluorouracil and its metabolites in complex biological matrices (mesenchymal stromal cells and tumour cells media) and for confirmation of the metabolic conversion of 5-fluorocytosine even in chemoresistant tumour cells media samples. For quantification, the LC-HESI QExactive MS method was developed and validated. The developed method demonstrated a very good linear range for 5-fluorocytosine from 1 ng/mL to 1000 ng/mL and for its major metabolites from 5 ng/mL to 1000 ng/mL. The limits of detection and limits of quantification ranged from 1.1 to 26 ng/mL and from 3.6 to 87 ng/mL, respectively. Both developed methods confirmed the ability of gene-directed enzyme prodrug therapy to metabolically convert 5-fluorocytosine to 5-fluorouracil and its major metabolites in real samples of tumour cell media and mesenchymal stromal cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024969
- 003
- CZ-PrNML
- 005
- 20211026134236.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jpba.2021.114168 $2 doi
- 035 __
- $a (PubMed)34089981
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Skvara, Pavel $u Comenius University in Bratislava, Faculty of Natural Sciences, Department of Analytical Chemistry, Ilkovičova 6, SK-842 15, Bratislava, Slovak Republic. Electronic address: skvara1@uniba.sk
- 245 10
- $a Development of LC-HRMS methods for evaluation of metabolic conversion of 5-fluorocytosine at GDEPT procedure / $c P. Skvara, E. Durinikova, K. Grabicová, E. Mordacikova, M. Matuskova, A. Vojs Stanova
- 520 9_
- $a Gene-directed enzyme/prodrug therapy represents one of the experimental treatment approaches. The system based on conversion of nontoxic prodrug 5-fluorocytosine to chemotherapeutic 5-fluorouracil by cytosine deaminase or fusion cytosine deaminase::uracil phosphoribosyl transferase belongs to the most frequently used. The detailed analysis of 5-fluorocytosine, 5-fluorouracil and its metabolites enables to understand various responses of tumour cells to treatment as well as mechanisms of resistance. A fast, sensitive and accurate methods based on liquid chromatography with high-resolution mass spectrometry (LC-HRMS) for the identification and quantification of 5-fluorocytosine, 5-fluorouracil and its major metabolites were developed. Two different hybrid high-resolution mass spectrometers sufficient for study of metabolic pathways were used. The LC-ESI IT-TOF MS method was successfully used for identification of 5-fluorocytosine, 5-fluorouracil and its metabolites in complex biological matrices (mesenchymal stromal cells and tumour cells media) and for confirmation of the metabolic conversion of 5-fluorocytosine even in chemoresistant tumour cells media samples. For quantification, the LC-HESI QExactive MS method was developed and validated. The developed method demonstrated a very good linear range for 5-fluorocytosine from 1 ng/mL to 1000 ng/mL and for its major metabolites from 5 ng/mL to 1000 ng/mL. The limits of detection and limits of quantification ranged from 1.1 to 26 ng/mL and from 3.6 to 87 ng/mL, respectively. Both developed methods confirmed the ability of gene-directed enzyme prodrug therapy to metabolically convert 5-fluorocytosine to 5-fluorouracil and its major metabolites in real samples of tumour cell media and mesenchymal stromal cells.
- 650 _2
- $a chromatografie kapalinová $7 D002853
- 650 _2
- $a cytosindeaminasa $7 D043525
- 650 12
- $a flucytosin $7 D005437
- 650 _2
- $a fluorouracil $7 D005472
- 650 _2
- $a hmotnostní spektrometrie $7 D013058
- 650 12
- $a prekurzory léčiv $7 D011355
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Durinikova, Erika $u Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, 845 05, Slovak Republic
- 700 1_
- $a Grabicová, Kateřina $u University of South Bohemia in České Budějovice, Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Zátiší 728/II, 389 25, Vodňany, Czech Republic
- 700 1_
- $a Mordacikova, Erika $u Comenius University in Bratislava, Faculty of Natural Sciences, Department of Analytical Chemistry, Ilkovičova 6, SK-842 15, Bratislava, Slovak Republic
- 700 1_
- $a Matuskova, Miroslava $u Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, 845 05, Slovak Republic
- 700 1_
- $a Vojs Stanova, Andrea $u Comenius University in Bratislava, Faculty of Natural Sciences, Department of Analytical Chemistry, Ilkovičova 6, SK-842 15, Bratislava, Slovak Republic; University of South Bohemia in České Budějovice, Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Zátiší 728/II, 389 25, Vodňany, Czech Republic
- 773 0_
- $w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 203, č. - (2021), s. 114168
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34089981 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026134242 $b ABA008
- 999 __
- $a ok $b bmc $g 1714145 $s 1145476
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 203 $c - $d 114168 $e 20210524 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
- LZP __
- $a Pubmed-20211013